Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Imdevimab Emergency use authorization Experimental Antiviral Jan/23/2023 31 11
Etesevimab Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022 5 16
BNT162b2 Approved by FDA Experimental Vaccine Jun/22/2022 64 0
S309 Potential treatment - pre-clinical evidence Experimental Antiviral Jun/22/2022 11 0
Tixagevimab Emergency use authorization Experimental Antiviral Jun/18/2022 9 3
Cilgavimab Emergency use authorization Experimental Antiviral Jun/18/2022 9 3
Convalescent plasma Emergency use authorization Experimental Antiviral May/16/2022 43 10
mAb 253 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022 6 0
mAb 58 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022 6 0
mAb Beta-29 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022 2 0